Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE-/- mice

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Ni, Jing Qin ^a   Ouyang, Qiufang ^a   Lin, Ling ^a   Huang, Ziyang ^a   Lu, Huixia ^b   Chen, Xiaoqing ^a   Lin, Huili ^a   Wang, Zhenhua ^a   Xu, Dongming ^a   Zhang, Yun ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; APOLIPOPROTEIN E; AUTOANTIBODY; B CELL ACTIVATING FACTOR; DOUBLE STRANDED DNA ANTIBODY; EOSIN; GAMMA INTERFERON; HEMATOXYLIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; AUTACOID; B RAF KINASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUNG INJURY; MACROPHAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; WILD TYPE; ANIMAL; AORTA SINUS; BLEEDING; BLOOD; DISEASE MODEL; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIBODIES, ANTINUCLEAR; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTOANTIBODIES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEMORRHAGE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG INJURY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTO-ONCOGENE PROTEINS B-RAF; SINUS OF VALSALVA; TOLL-LIKE RECEPTOR 4;

EID: 84887484790     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/476856     Document Type: Article

References (27)

1. Fernández-Nebro A., Marsal S., Chatham W., Systemic lupus erythematosus: genomics, mechanisms, and therapies. Clinical and Developmental Immunology 2012 2012 2 926931 10.1155/2012/926931
2. Bessant R., Duncan R., Ambler G., Swanton J., Isenberg D. A., Gordon C., Rahman A., Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Care and Research 2006 55 6 892 899 2-s2.0-33845509278 10.1002/art.22343
3. Barker T. T., Lee P. Y., Kelly-Scumpia K. M., Weinstein J. S., Nacionales D. C., Kumagai Y., Akira S., Croker B. P., Sobel E. S., Reeves W. H., Satoh M., Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane. Laboratory Investigation 2011 91 10 1540 1550 2-s2.0-80053367444 10.1038/labinvest.2011.108
4. Sireci G., Guggino G., Giardina A. R., Ciccia F., Triolo G., Dieli F., Are toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? Clinical and Developmental Immunology 2012 2012 5 2-s2.0-80053550874 10.1155/2012/135932 135932
5. Croca S. C., Rahman A., Imaging assessment of cardiovascular disease in systemic lupus erythematosus. Clinical and Developmental Immunology 2012 2012 7 2-s2.0-84855175069 10.1155/2012/694143 694143
6. Lee T.-P., Tang S.-J., Wu M.-F., Song Y.-C., Yu C.-L., Sun K.-H., Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. Journal of Autoimmunity 2010 35 4 358 367 2-s2.0-77958151180 10.1016/j.jaut.2010.07.007
7. Liu B., Yang Y., Dai J., Medzhitov R., Freudenberg M. A., Zhang P. L., Li Z., TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. Journal of Immunology 2006 177 10 6880 6888 2-s2.0-33750831778
8. Ostos M. A., Recalde D., Zakin M. M., Scott-Algara D., Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Letters 2002 519 1-3 23 29 2-s2.0-0037157103 10.1016/S0014-5793(02)02692-3
9. Michelsen K. S., Wong M. H., Shah P. K., Zhang W., Yano J., Doherty T. M., Akira S., Rajavashisth T. B., Arditi M., Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 2004 101 29 10679 10684 2-s2.0-3242710174 10.1073/pnas.0403249101
10. Yuehai W., Ziyang H., Huixia L., Apolipoprotein E-knockout mice show increased titers of serum anti-nuclear and anti-dsDNA antibodies. Biochemical and Biophysical Research Communications 2012 423 4 805 812
11. Massaro D., Massaro G. D., Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function. American Journal of Physiology 2008 294 5 L991 L997 2-s2.0-45849119049 10.1152/ajplung.00013.2008
12. Xianglan Y., Vitek M. P., Alan T., Apolipoprotein mimetic peptides: a new approach for the treatment of asthma. Frontiers in Pharmacology 2012 3, article 37
13. Nandedkar S. D., Weihrauch D., Xu H., Shi Y., Feroah T., Hutchins W., Rickaby D. A., Duzgunes N., Hillery C. A., Konduri K. S., Pritchard K. A. Jr., D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma. Journal of Lipid Research 2011 52 3 499 508 2-s2.0-79953206963 10.1194/jlr.M012724
14. Jofre-Monseny L., Minihane A.-M., Rimbach G., Impact of apoE genotype on oxidative stress, inflammation and disease risk. Molecular Nutrition and Food Research 2008 52 1 131 145 2-s2.0-38949163967 10.1002/mnfr.200700322
15. Herndon T. M., Juang Y.-T., Solomou E. E., Rothwell S. W., Gourley M. F., Tsokos G. C., Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clinical Immunology 2002 103 2 145 153 2-s2.0-0036264363 10.1006/clim.2002.5192
16. Enzler T., Bonizzi G., Silverman G., Otero D. C., Widhopf G., Anzelon-Mills A., Rickert R., Karin M., Alternative and classical NF- B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006 25 3 403 415 2-s2.0-33748441252 10.1016/j.immuni.2006.07.010
17. Moon E.-Y., Lee Y.-S., Choi W. S., Lee M.-H., Toll-like receptor 4-mediated cAMP production up-regulates B-cell activating factor expression in Raw264.7 macrophages. Experimental Cell Research 2011 317 17 2447 2455 2-s2.0-80052634953 10.1016/j.yexcr.2011.07.003
18. Kim S.-J., Park J.-H., Kim K.-H., Lee W.-R., Lee S., Kwon O.-C., Kim K.-S., Park K.-K., Effect of NF- B decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model. Basic and Clinical Pharmacology and Toxicology 2010 107 6 925 930 2-s2.0-78649542282 10.1111/j.1742-7843.2010. 00617.x
19. Vink A., Schoneveld A. H., Van der Meer J. J., Van Middelaar B. J., Sluijter J. P. G., Smeets M. B., Quax P. H. A., Lim S. K., Borst C., Pasterkamp G., De Kleijn D. P. V., In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 2002 106 15 1985 1990 2-s2.0-0037044401 10.1161/01.CIR.0000032146.75113.EE
20. Hussey S. E., Liang H., Costford S. R., TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid induced inflammation and insulin resistance in muscle cells. Bioscience Reports 2012 33 1 37 47
21. Takashima K., Matsunaga N., Yoshimatsu M., Hazeki K., Kaisho T., Uekata M., Hazeki O., Akira S., Iizawa Y., Ii M., Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. British Journal of Pharmacology 2009 157 7 1250 1262 2-s2.0-70350304545 10.1111/j.1476-5381.2009.00297.x
22. -/- mice. PLoS One 2013 8 4, article e60430
23. Davies J. M., MacSharry J., Shanahan F., Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells. Immunology 2010 131 3 438 448 2-s2.0-78649403533 10.1111/j.1365-2567.2010.03317. x
24. Veeresh B. H., Hiremath S. V., Patiln S. S., Tissues-specific mRNA expression pattern of swine toll-like receptors (TLRs) 1-10. Journal of Veterinary Science and Technology 2012 1 2 14 23
25. Yu S.-L., Kuan W.-P., Wong C.-K., Li E. K., Tam L.-S., Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus. Clinical and Developmental Immunology 2012 2012 14 2-s2.0-84858256988 10.1155/2012/715190 715190
26. La Cava A., Anticytokine therapies in systemic lupus erythematosus. Immunotherapy 2010 2 4 575 582 2-s2.0-77955008714 10.2217/imt.10.29
27. Ali K., Middleton M., Puré E., Rader D. J., Apolipoprotein E suppresses the type I inflammatory response in vivo. Circulation Research 2005 97 9 922 927 2-s2.0-27644482670 10.1161/01.RES.0000187467.67684.43